SCHEMBL8435137

SCHEMBL8435137

CCC(OC(=O)C(Cc1csc(-c2ccccc2)n1)NC(CC(C)C)C(=O)OC(C)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
RAB9A P51151 6/20 0.38
MAPT P10636 3/20 0.38
NPC1 O15118 3/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
CTSK P43235 1/20 0.37
TP53 P04637 2/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
PKM P14618 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HPGD P15428 1/20 0.36
ACKR3 P25106 1/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8256313 1.00 ALDH1A1 (0.39) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8256627 0.90 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8430315 0.90 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8256311 0.90 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8436235 0.90 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8248591 0.83 KDM4E (0.43) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8434209 0.83 KDM4E (0.43) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL5870222 0.81 MAPT (0.48) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8434032 0.80 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1
SCHEMBL8430308 0.80 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof ACE, ACE2, AGTR2 ALDH1A1 1305/4885KDM4E 2662/4885RAB9A 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.